Condition

Systemic Light Chain Amyloidosis clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• TQB2934 injection for systemic light chain amyloidosis

  This trial will test whether a subcutaneous injection of TQB2934 is safe and can improve blood response in adults with relapsed or refractory systemic light chain amyloidosis who have had daratumumab and bortezomib.

  Recruiting Phase 1/2 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Beijing, Beijing Municipality and 26 other locations · NCT07266116

• Low-dose BCMA/CD3 (CM336) treatment for newly diagnosed AL (light-chain) amyloidosis

  This trial will try a low-dose BCMA/CD3 bispecific antibody (CM336) in adults newly diagnosed with systemic light-chain (AL) amyloidosis to see if it is safe and lowers abnormal light-chain levels and helps organ function.

  Recruiting Phase 2 Institute of Hematology & Blood Diseases Hospital, China · Tianjin · NCT07151690

Quick answers

How many Systemic Light Chain Amyloidosis clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →